Nasséra Chalabi

1.3k total citations
37 papers, 832 citations indexed

About

Nasséra Chalabi is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Nasséra Chalabi has authored 37 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Nasséra Chalabi's work include Nutrition, Genetics, and Disease (7 papers), Breast Cancer Treatment Studies (7 papers) and HER2/EGFR in Cancer Research (6 papers). Nasséra Chalabi is often cited by papers focused on Nutrition, Genetics, and Disease (7 papers), Breast Cancer Treatment Studies (7 papers) and HER2/EGFR in Cancer Research (6 papers). Nasséra Chalabi collaborates with scholars based in France, Switzerland and Australia. Nasséra Chalabi's co-authors include Dominique Bernard-Gallon, Yves‐Jean Bignon, Laëtitia Delort, Ludovic Le Corre, Samir Satih, Nadège Rabiau, Fabrice Kwiatkowski, Y. J. Bignon, Pierre Fustier and Rémy Bosviel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Nasséra Chalabi

36 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasséra Chalabi France 16 385 234 188 181 156 37 832
Jae Young So United States 18 447 1.2× 323 1.4× 204 1.1× 170 0.9× 159 1.0× 24 969
Samir Satih France 14 363 0.9× 85 0.4× 101 0.5× 134 0.7× 145 0.9× 19 570
Rajnee Kanwal United States 14 973 2.5× 166 0.7× 372 2.0× 78 0.4× 94 0.6× 24 1.3k
Daniele G. Soares France 14 439 1.1× 277 1.2× 143 0.8× 45 0.2× 38 0.2× 29 820
Mohammad R. Salabat United States 13 516 1.3× 258 1.1× 217 1.2× 59 0.3× 50 0.3× 24 1.1k
Brijesh B. Patel United States 9 307 0.8× 133 0.6× 177 0.9× 115 0.6× 34 0.2× 19 608
Rémy Bosviel France 13 406 1.1× 55 0.2× 114 0.6× 132 0.7× 147 0.9× 18 589
Soley Bayraktar United States 21 752 2.0× 761 3.3× 425 2.3× 297 1.6× 347 2.2× 65 1.8k
Laurie J. Hafer United States 14 293 0.8× 225 1.0× 118 0.6× 169 0.9× 192 1.2× 15 762

Countries citing papers authored by Nasséra Chalabi

Since Specialization
Citations

This map shows the geographic impact of Nasséra Chalabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasséra Chalabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasséra Chalabi more than expected).

Fields of papers citing papers by Nasséra Chalabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasséra Chalabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasséra Chalabi. The network helps show where Nasséra Chalabi may publish in the future.

Co-authorship network of co-authors of Nasséra Chalabi

This figure shows the co-authorship network connecting the top 25 collaborators of Nasséra Chalabi. A scholar is included among the top collaborators of Nasséra Chalabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasséra Chalabi. Nasséra Chalabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chalabi, Nasséra, Sally El Kantar, Anissa Khelfa, et al.. (2024). Improving the Synthesis of Odd-Chain Fatty Acids in the Oleaginous Yeast Yarrowia lipolytica. Fermentation. 10(12). 597–597. 4 indexed citations
4.
Westphalen, C. Benedikt, Chantal Pauli, Nasséra Chalabi, et al.. (2023). Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study. ESMO Open. 8(6). 102035–102035. 7 indexed citations
6.
Jacquin, Jean-Philippe, Lionel Uwer, Alexia Savignoni, et al.. (2019). Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study. The Breast. 49. 1–7. 5 indexed citations
7.
Benchoufi, Mehdi, et al.. (2018). Epidemium: A multidisciplinary community to tackle cancer using big and open data.. Journal of Clinical Oncology. 36(15_suppl). e13604–e13604. 2 indexed citations
8.
Chalabi, Nasséra, Catherine Abrial, Nina Radosevic‐Robin, et al.. (2015). Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?. Critical Reviews in Oncology/Hematology. 95(1). 88–104. 68 indexed citations
9.
Satih, Samir, Nasséra Chalabi, Nadège Rabiau, et al.. (2010). Gene Expression Profiling of Breast Cancer Cell Lines in Response to Soy Isoflavones Using a Pangenomic Microarray Approach. OMICS A Journal of Integrative Biology. 14(3). 231–238. 33 indexed citations
10.
Rabiau, Nadège, Myriam Kossaï, Nasséra Chalabi, et al.. (2010). Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by Polymerase Chain Reaction arrays in human prostate cancer cell lines. Cancer Epidemiology. 34(2). 200–206. 60 indexed citations
11.
Delort, Laëtitia, Nasséra Chalabi, Samir Satih, et al.. (2009). Association between genetic polymorphisms and ovarian cancer risk.. PubMed. 28(5B). 3079–81. 34 indexed citations
12.
Fontana, Luc, Rémy Bosviel, Laëtitia Delort, et al.. (2008). DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.. PubMed. 28(3B). 1853–6. 46 indexed citations
13.
Bernard-Gallon, Dominique, Rémy Bosviel, Laëtitia Delort, et al.. (2008). DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Molecular Cancer. 7(1). 36–36. 39 indexed citations
14.
Chalabi, Nasséra, Samir Satih, Laëtitia Delort, Yves‐Jean Bignon, & Dominique Bernard-Gallon. (2007). Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1769(2). 124–130. 29 indexed citations
15.
Delort, Laëtitia, Fabrice Kwiatkowski, Nasséra Chalabi, et al.. (2007). Risk factors for early age at breast cancer onset--the "COSA program" population-based study.. PubMed. 27(2). 1087–94. 9 indexed citations
16.
Chalabi, Nasséra, Dominique Bernard-Gallon, Marie‐Paule Vasson, & Yves‐Jean Bignon. (2007). Nutrigenomics and Antioxidants. Personalized Medicine. 5(1). 25–36. 5 indexed citations
17.
Corre, Ludovic Le, Nasséra Chalabi, Laëtitia Delort, Yves‐Jean Bignon, & Dominique Bernard-Gallon. (2006). Differential Expression of Genes Induced by Resveratrol in Human Breast Cancer Cell Lines. Nutrition and Cancer. 56(2). 193–203. 16 indexed citations
18.
Satih, Samir, Nasséra Chalabi, Laëtitia Delort, et al.. (2006). BRCA1 specific knockdown by RNA interference in human tumor breast cell lines.. 81–94. 1 indexed citations
19.
Corre, Ludovic Le, Pierre Fustier, Nasséra Chalabi, Yves‐Jean Bignon, & Dominique Bernard-Gallon. (2004). Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clinica Chimica Acta. 344(1-2). 115–121. 40 indexed citations
20.
Bernard-Gallon, Dominique, et al.. (2004). Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia.. PubMed. 24(1). 321–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026